Novel antimicrobial peptide
US5032574A · kind A · utility
18Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 1988 |
| Grant date | Jul 16, 1991 |
| Priority date | — |
| Expiry date | May 26, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a purified polypeptide useful as an antimicrobial agent. This purified polypeptide has been derived from human granulocytes, and has a molecular weight of about 3,700 daltons and the N-terminal amino acid sequence val-cys-ser-cys-arg-leu-val-phe-cys-arg-arg-thr-glu- leu-arg-val-gly-asn-cys-leu-ile-gly-gly-val-ser-phe-thr-try-cys-thr-arg-va l. This invention also provides methods for producing this polypeptide, pharmaceutical compositions containing the polypeptide, and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.